A next generation, high capacity protein A chromatography resin for advanced protein separation in downstream processing.
Amsphere A3 is a next generation Protein A chromatography resin for advanced protein separation in downstream processing of therapeutic antibodies manufacturing.
Besides an outstanding high capacity, Amsphere A3 has an overall improved process robustness, flow characteristics, optimized impurity removal, productivity and resin lifetime.
Join Ying Yao, JSR’s Applications Scientist, for a webinar on comparative purification analysis of Fc-fusion proteins.
New Vice President to lead North America and Europe Business Development
San Diego, California, July 20, 2021 – Crown Bioscience, a JSR Life Sciences company, today announces the appointment of Alex Slater as Vice President of Business Development, North America and Europe. In this role, Mr...
Geneva, Switzerland, and Durham, NC – June 29, 2021 – Selexis SA and KBI Biopharma (KBI), both JSR Life Sciences companies, announced today that they have signed service agreements with Immatics N.V. (NASDAQ: IMTX; “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and...
Agreement supports future commercial manufacturing for AM-Pharma’s recombinant alkaline phosphatase program
Utrecht, The Netherlands and DURHAM, NC – June 17, 2021 – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, and AM-Pharma, an emerging leader focused on the development of therapeutics...
Extending the lifetime of Protein A resin during the downstream process of manufacturing a biomolecule can have significant positive effects on your process economy. In this webinar, NaOH in combination with ethylene glycol, ethanol, IPA, and thioglycerol are examined. Bacterial challenge, soaking, and life cycle data on Amsphere A3 resin using PAA will be presented.